2009
Topics in this newsletter include:
- PRO: Recombinant Activated Factor VII Should Be Used Early After Cardiac Surgery
- CON: Recombinant Activated Factor VII Should Only Be Used as Salvage Therapy After Cardiac Surgery
- PRO: Start the Drip
- CON: Avoid the Loop
- Concise Review
- Literature Review I
- Literature Review II
- Literature Review III: Exploring Intensive Insulin Therapy In-Depth
- Fellowship Review I: Yale University, Department of Anesthesiology Critical Care
- Fellowship Review II: Columbia University
- Fellowship Review III: Johns Hopkins Critical Care Fellowship